(2,3-Difluoro-4-hydroxyphenyl)boronic acid, 95.0%, 5g

Colonne capillaire GC ROTI®Cap-5, 60 m, 0,25 mm, 0,50 µm, 1 pièce(s)

3-Iodo-2-methoxypyridine>98.0%(GC)(T)5g

TERT-BUTYL (3S,5R)-3-FLUORO-5-HYDROXYPIPERIDINE-1-CARBOXYLATE, 95%, 1g

Piperidine-2,4-dione, 97.0%, 10g

Thalidomide-O-amido-C8-NH2 (TFA), 100mg

N,N'-(Ethane-1,2-diyl)bis(1-phenylmethanimine), 95%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(allyloxy)phenyl)propanoic acid, 98.0%, 5g

ETHYL 3-AMINO-1-(4-BROMOPHENYL)-1H-PYRROLE-2-CARBOXYLATE HCL, 95.0%, 100mg

(4-methyl-2-thienyl)boronic acid tetrahydrate, 95.0%, 1g

tert-Butyl (2-(4-cyanophenyl)-2-oxoethyl)carbamate, 100mg

Ethylenediaminetetraacetic Dianhydride>98.0%(T)100g

2,3,4,6-Tetra-O-benzyl-beta-D-glucopyranosyl Fluoride>96.0%(HPLC)500mg